Barely Significant
← all phrases

“a numerical trend”

1,013 sentences · 1,013 papers · 1,817 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

In CAPTAIN prespecified analyses [ 27 ], there was a numerical trend for a greater reduction in moderate/severe attacks among ex-smokers versus patients without smoking history after adding UMEC to FF/VI, although, as with other studies, the number of ex-smokers was low versus the other subgroups, and smoking history was limited (i.e., < 10 pack years).
There was a numerical trend for the daily pasture allowance (kg of DM/ha) to be reduced with the increase in experiment duration when cows grazed from mid-January to mid-March, and the highest allowance during the first grazing period reflects the lack of pasture mowing before the start of the experiment ( Figure 3 ).
11 A previous individual participant meta-analysis ( N = 19,047) did suggest a numerical trend toward a benefit for cardiovascular death at 30 days in patients with TIMI thrombus grade ≥3 compared with usual care (2.5% vs 3.1%; HR, 0.80; 95% CI, 0.65-0.98; P = .03), although no significant interaction was found ( P = .32). 11 Randomized trials testing newer mechanical thrombectomy devices should be performed, as continuous suction may provide better thrombus clearance and a lower risk of thrombus embolization causing stroke.
Notably: (1) Despite lacking statistical significance, a numerical trend was observed: the lowest median level (14.0 ng/mL) occurred in the 15‐16‐year group, while the highest median level (18.2 ng/mL) was found in the ≥17‐year group; (2) Substantial variability was evident, with all groups exhibiting interquartile ranges (IQR) spanning approximately 7–8 ng/mL (e.g., 15‐16‐year group: 12.5–20.8 ng/mL).
Taken together with the analysis of the primary endpoint in Table 3 , these results show that there is a numerical trend of continuous improvement in pain (API-NRS) from baseline to week 6 and a stabilization of the response between 6 and 8 weeks (ie, no additional improvement in pain intensity) in the LY3526318 arm, while the response to placebo shows continuous improvement.